Tejal Merchantile

Founder Ajay Krishnakant Parikh and director Nihar Ajay Parikh appear to control investment decisions. Anuja Saumik Doshi, listed as a director across related entities, rounds out the governance circle. The firm has no known external investment committee or disclosed non-family principals.

It operates as a hybrid. Legally structured as an investment company rather than a trust or pure family office, it manages proprietary capital with no evidence of external limited partners. The presence of a related venture vehicle—4Point0 Health Ventures, founded by Nihar Parikh—suggests a segmented architecture where healthcare investments sit outside the core entity.

Confirmed assets include commercial office units at One World Centre (Tower 2B, Lower Parel) and Omkar 1973 (Tower B, Worli), both in Mumbai. On the operating side, the firm holds a software asset called Docuinsights and a registered trademark for '4point0,' linked to Nihar Parikh's health ventures platform.

Nihar Parikh serves as a director of Tejal Merchantile while separately founding 4Point0 Health Ventures. The two entities appear to operate under common family control but with distinct mandates—Tejal Merchantile as the generalist holding company and 4Point0 as the healthcare-focused venture arm. Nihar's independent directorships at Gujarat Themis Biosyn and Kusumgar Limited reinforce the healthcare and industrial connections.

There is no public record of Tejal Merchantile raising external funds, operating a fund structure, or soliciting limited partners. The firm's complete absence from fundraising databases and its tight family-director governance strongly suggest it deploys proprietary capital exclusively.

Altss research tags the firm's strategy as expansion and late-stage. This aligns with the generalist holding-company model—later-stage deployments that require less hands-on operational involvement than early-stage venture, consistent with a lean family-run investment office.

Director Nihar Parikh holds independent director seats at Gujarat Themis Biosyn Limited and Kusumgar Limited, both publicly traded in India. These roles provide visibility into the pharmaceutical and specialty-chemical sectors but do not necessarily indicate equity positions held by Tejal Merchantile itself.